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determined. The speciﬁcity of the antiserum was further
identiﬁed by immuno blotting system in which the antiserum
reacted with the puriﬁed AhpC protein and whole cell pro-
tein extract from H.pylori in addition to the intact cells of
H.pylori.
Conclusion: This method is simple and rapid and gives
high speciﬁc polyclonal antibody without any puriﬁcation of
serum or antigen and the antibody would be useful in stool
antigen test for detection of H.pylori infection.
doi:10.1016/j.ijid.2008.05.417
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Signiﬁcance of Cell Cycle Manipulation in the Establish-
ment of Dengue Virus and West Nile Virus Infection
M.K. Chong ∗, M.L. Ng
National University of Singapore, Singapore, Singapore
Background: Dengue virus infection has been classiﬁed
as medically important infectious disease in tropical and
subtropical countries while West Nile virus is another emerg-
ing infectious disease that potentially causes threat from
America to Asia. The mechanism of the virus to establish its
infection in the host cell after entry still remains elusive.
This project aims to investigate how Dengue virus (DENV)
and West Nile virus (WNV) manipulate host cell cycle to
establish its infection.
Methods: Fluorescence activated cell sorting (FACS) anal-
ysis was carried out to determine the cell cycle phases at
different time courses after infection. Two cell lines - Baby
Hamster Kidney (BHK) cells and mosquito cells C6/36, were
used for DENV and WNV infection. Virus titers for each time
course were determined through plaque assay while the cells
were stained with propidium iodide for cell cycle analysis.
Results and Conclusion: The results of FACS analysis
showed that WNV arrested BHK cells cycle at S phase after
synchronized infection when compared to mock-infected
cells. When BHK cells were arrested at G1 phase after infec-
tion via serum starvation, WNV was shown to be able to
overcome this constraint and trigger S phase entry. Simi-
lar results were also observed for DENV infection on BHK
cells. Interestingly, DENV arrested C6/36 cell cycle at G2/M
phase after synchronized infection. These results showed
that DENV and WNV have evolved a strategy to manipulate
the host cell cycle for virus production. The strategy appears
to be host cell speciﬁc as seen in BHK and C6/36 cells. Stud-
ies of the interaction between viral proteins and host cell
proteins are currently carried out to reveal the molecular
mechanism underlying the manipulation of cell cycle.
doi:10.1016/j.ijid.2008.05.418
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Beneﬁcial Effects of Biotherapeutics in the Management
of Experimentally Induced CDAD in BALB/C Mice
S. Kaur, C. Vaishnavi ∗, K.K. Prasad, P. Ray, R. Kochhar
Postgraduate Institute of Medical Education and Research,
Chandigarh, India
Background: Clostridium difﬁcile associated disease
(CDAD) is the most common hospital acquired infec-
tion. Antimicrobial treatment predisposes the patient to
recurrent CDAD. Biotherapeutic approaches by employing
probiotic and epidermal growth factor (EGF) could help
in the management of CDAD. BALB/c mice experimentally
inoculated with C. difﬁcile were investigated to assess the
beneﬁcial effects of Lactobacillus acidophilus and epider-
mal growth factor for the management.
Methods: The animals were investigated for physical
changes and other parameters which included colonization
and toxin production by C. difﬁcile, serum anti-toxin IgG lev-
els, tight junction proteins, myeloperoxidase activity (MPO)
and histopathological changes in the intestinal tract.
Results: C. difﬁcile count, toxins A and B titers and MPO
activity were signiﬁcantly lowered (P < 0.05) in the groups
receiving probiotic and EGF compared to those not receiv-
ing the biotherapeutics. A signiﬁcant increase (P < 0.05) in
IgG levels were found in the serum samples of animals
belonging to C. difﬁcile and cyclosporine groups after L. aci-
dophilus administration. In antibiotic group also, there was
an insigniﬁcant increase in IgG level after probiotic admin-
istration. It was observed that oral administration of EGF
did not show any effect on the serum IgG levels in any of
the groups. Tight junction proteins were present in more
number of animals receiving probiotic and EGF. Histopatho-
logically mucodepletion, cryptitis and neutrophilic inﬁltrate
were decreased in cecum and colon of probiotic and EGF
receiving subgroups.
Conclusion: Probiotic and EGF administration signiﬁ-
cantly decreased the C. difﬁcile count, toxin titers and
degree of inﬂammation in drug induced CDAD in animals.
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Hemophagocytic syndrome (HPS) is a fatal complication
of severe viral infections such as Epstein-Barr virus (EBV) and
recently, SARS CoV and H5N1 inﬂuenza. The pathogenesis of
HPS is presumed to result from an enhanced Th1 cytokine
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secretion and systemic macrophage activation. Since per-
oxisome proliferators activated receptor (PPAR) agonists,
regulators of cholesterol metabolism, have been shown to
exhibit profound effects on the inhibition of proinﬂamma-
tory cytokines and macrophage activation, rosiglitazone, a
PPAR-gamma agonist, was adopted for the potential con-
trol of HPS using a rabbit model of Herpesvirus papio
(HVP, an EBV homologue)-associated HPS. In vitro, rosigli-
tazone was shown to inhibit macrophage activation and
secretion of tumor necrosis factor-alpha through inhibi-
tion of NFkB signaling in U937 cell line. Different doses of
rosiglitazone were fed to rabbits after intravenous injec-
tion of 5× 107 copies of HVP virus at different time courses
(7 days and 20 days, respectively) of infection. As com-
pared to the control group which succumbed consistently
at around one month, the 4mg rosiglitazone-treated group
showed signiﬁcant improvement of survival when fed at
early stage (7 days) of infection (p < 0.01), while a higher
dosage (8mg) is needed to achieve therapeutic effect at
advanced stage (20 days) of infection (p < 0.05). The viral
load, TNF-alpha cytokine levels, and laboratory parameters
also showed signiﬁcant improvement in the rosiglitazone-
treated group. Therefore, rosiglitazone, in addition to its
therapeutic effect for metabolic syndrome, appears to rep-
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Background: Dengue virus (DENV), a member of the Fla-
viviridae family is the leading cause of diseases ranging
from febrile Dengue Fever to life-threatening Dengue Hem-
orrhagic Fever/Dengue Shock Syndrome. Each year, millions
are infected with the virus; however, the race to ﬁnd a
suitable therapy or prophylaxis for DENV is complicated
by the existence of 4 serotypes of DENV and the advent
of antibody-mediated enhancement (ADE). In the light of
this re-emerging disease, our group has taken the proac-
tive approach to study the entry pathway of Dengue virus
serotype 2 (DENV2) into HepG2 hepatocytes. Armed with this
new-found knowledge, we hope to be able to contribute fur-
ther to the understanding and the development of effective
anti-dengue strategies.
Methods: Our experiment was divided into three main
areas; (1) using drug inhibitory assays against candidate
host factors mediating virus endocytosis, (2) using molec-
ular inhibitors and siRNA molecules against these host
factors as a molecular approach to supplement our results
and (3) employing the use of indirect immunoﬂuorescence
microscopy for bio-imaging studies tracking DENV2 entry
into HepG2 within the ﬁrst 30 minutes of infection.
Results: Our virus growth curve shows productive DENV2
infection of HepG2 cells from the point of infection to 10
days post-infection. We embarked on using small molecule
drugs against host factors identiﬁed as having a crucial role
in mediating DENV2 entry into HepG2 cells. These include
clathrin, acidiﬁcation of endosomes, host cytoskeleton net-
work (actin and microtubule) as well as lipid rafts. All drug
inhibition assays carried out show a non-cytotoxic dose-
dependent inhibition of DENV2 entry into cells. Likewise,
we used molecular inhibitors and siRNA molecules against
these cellular factors showed similar results. Finally, our bio-
imaging studies further reveal a stepwise entry of DENV2
into HepG2 cells starting with clathrin-mediated endocy-
tosis followed by co-localization with early and then late
endosomes.
Conclusion: Our study gives us a ﬁrst glimpse of the intri-
cate interaction of host factors that mediate DENV2 entry
into HepG2 cells and provides us with an avenue to develop
therapeutic approached to target this crucial initial interac-
tion to combat DENV infection in general.
doi:10.1016/j.ijid.2008.05.421
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Infection Control Assessment in Private Dental Clinics of
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V. Alipour ∗, A.M. Araghizadeh, L. Rezaei
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Background: Infection control programs in dental clinics
are essential to prevent of infectious transmission among
personnel and patients. The program usually starts by eval-
uation of risk factors and completed by designing a suitable
strategy for removal of them. The present study assessed
the infection control situation of private dental ofﬁces in
Bandar Abbas, southern Iran, during year 2006.
Materials & Methods: sixty dental were investigated
using a cross- sectional study in a 6 months period. A stan-
dard questionnaire was used to collect data (correspondence
rate was 82%). The questionnaire contained 46 questions
about demographic information, knowledge and practice of
dentists about infection control and hygienic condition of
clinics. Data was analyzed using T and Pearson tests.
Results: vaccination rate against hepatitis B was 43.5
percent, among selected dentists, 75% of them were not
conﬁdent about antibody production in their body. Eighty
and 15% of questioned dentists used personal protec-
tion equipments and mouth washing solution respectively.
Correct answer to questions on instruments sterilization,
properly hand washing procedures and subcutaneous infec-
tion control were 74, 56.7 and 34 percent respectively.
Special containers were used for infectious disposal in 82
percent, of which, 60 percent were labeled. Seventy four
percent of dentists were conﬁdent about accurate steriliza-
tion of instruments, but 50% of them were not conﬁdent
that instruments remained sterilized till operation. Average
score of knowledge, practice, and hygienic clinics situa-
tion in female and male dentist were (10.1 ± is & # 1.73,
11.1± is & # 1.79), (14.4± is± 1.40, 13.6± is± 1.73) and
(16.6± is ± 1.13, 16± is± 1.26) respectively.
Conclusion: In our quality assessments, the knowledge
and practice level of selected dentists were intermedi-
ate and environmental health situation of clinics was ﬁnd
high scored. According to relationship between knowledge
